Study of the Effectiveness and Clinical Practice Use of Glecaprevir Plus Pibrentasvir in Patients With Chronic Hepatitis C Genotypes 1 to 6
Study description
Evidenza dal mondo reale dell'efficacia e dell'utilizzo nella pratica clinica di Glecaprevir più Pibrentasvir in pazienti affetti da Epatite C cronica genotipi da 1 a 6
Pathology
Hepatitis C Virus HCV
Study type
Post-marketing observation study
Status
Active
Study start date
2017
Study completion date
2019
Funder Type
Industry funded study
Investigator
Dr. med. Lorenzo MAGENTA
Recruitment
Recruiting
For information, please contact the Foundation